Intco Medical Technology Co (300677.SZ) Stock Price
Intco Medical Technology Co Price
Over the last 12 years Intco Medical Technology Co grew revenue by 24.5% annually, reaching 9.93 B CNY. Earnings per share have grown at 46.1% per year over the last 12 years. For Intco Medical Technology Co, the net margin of 10.2% is down versus 45.8% a few years ago. At today's price the dividend yield works out to roughly 0.30%. The payout ratio is around 9% of earnings. The dividend has grown at 27.2% per year over the past 7 years. The consensus 12-month price target for Intco Medical Technology Co is 35.42 CNY, about 28.1% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
Intco Medical Technology Co stock price
Intco Medical Technology Co business model & stock analysis
Frequently asked questions about Intco Medical Technology Co
Analysts currently set an average price target of 35.42 CNY for the Intco Medical Technology Co stock (median: 35.42 CNY), implying -28.1 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the Intco Medical Technology Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Intco Medical Technology Co to generate revenue of 15.06 B CNY and earnings per share of 3.80 CNY.
Converted at the current exchange rate, the Intco Medical Technology Co share trades at 6.47 EUR (49.26 CNY).
The Intco Medical Technology Co share (300677.SZ) is listed on 1 stock exchanges, including: Shenzhen (300677.SZ).
The expected revenue of Intco Medical Technology Co is 15.06 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Intco Medical Technology Co is 2.39 B CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Intco Medical Technology Co is currently 12.96. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Intco Medical Technology Co stock.
The price-to-sales ratio (P/S) of Intco Medical Technology Co is currently 2.06. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Intco Medical Technology Co stock.
The Eulerpool Quality Score for Intco Medical Technology Co is 7/10.
The ISIN of Intco Medical Technology Co is CNE100003456. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Intco Medical Technology Co is 300677.SZ. The ticker symbol is used to trade Intco Medical Technology Co shares on the stock exchange.
Intco Medical Technology Co stock
Intco Medical Technology Co Peer Group
Intco Medical Technology Co Ticker
Intco Medical Technology Co FIGI
All fundamentals and in-depth analysis of Intco Medical Technology Co
Our stock analysis for Intco Medical Technology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intco Medical Technology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.